Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000734492 | SCV000862640 | uncertain significance | not provided | 2018-08-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000734492 | SCV001802472 | likely benign | not provided | 2020-07-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001855815 | SCV002291503 | benign | Kabuki syndrome | 2025-01-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002536521 | SCV003555232 | likely benign | Inborn genetic diseases | 2021-07-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004540074 | SCV004779968 | likely benign | KMT2D-related disorder | 2023-12-18 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |